<SEC-DOCUMENT>0001978034-25-000001.txt : 20250129
<SEC-HEADER>0001978034-25-000001.hdr.sgml : 20250129
<ACCEPTANCE-DATETIME>20250129163022
ACCESSION NUMBER:		0001978034-25-000001
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250129

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Jaguar Health, Inc.
		CENTRAL INDEX KEY:			0001585608
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-88872
		FILM NUMBER:		25569759

	BUSINESS ADDRESS:	
		STREET 1:		200 PINE STREET SUITE 400
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
		BUSINESS PHONE:		415-371-8300

	MAIL ADDRESS:	
		STREET 1:		200 PINE STREET SUITE 400
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Jaguar Animal Health, Inc.
		DATE OF NAME CHANGE:	20130830

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Uptown Capital, LLC
		CENTRAL INDEX KEY:			0001978034
		ORGANIZATION NAME:           	
		IRS NUMBER:				861320537
		STATE OF INCORPORATION:			UT

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		303 E WACKER DRIVE
		STREET 2:		SUITE 1040
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60601
		BUSINESS PHONE:		3122977000

	MAIL ADDRESS:	
		STREET 1:		303 E WACKER DRIVE
		STREET 2:		SUITE 1040
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60601
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001978034</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common stock, Par Value $0.0001 Per Share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>01/29/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001585608</issuerCik>
        <issuerName>Jaguar Health, Inc.</issuerName>
        <issuerCusip>47010C805</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>200 PINE STREET SUITE 400</com:street1>
          <com:city>SAN FRANCISCO</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94104</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>John Fife and Fredrick Waid</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>1290000.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>1290000.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1290000.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>9.9</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>*John Fife has sole voting and dispositive power over 1,290,000 shares.

** 12,900 shares owned on behalf of John Fife; 1,277,100 shares owned on behalf of Fredrick Waid.

*** Based on 13,088,288 shares outstanding.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Jaguar Health, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>200 PINE STREET SUITE 400, SAN FRANCISCO, CALIFORNIA, 94104</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>John M Fife
Fredrick Waid</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>John M Fife:

303 East Wacker Drive, Suite 1040
Chicago, IL 60601

Fredrick Waid:

303 East Wacker Drive, Suite 1040
Chicago, IL 60601</principalBusinessOfficeOrResidenceAddress>
        <citizenship>United States of America</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>12,900</amountBeneficiallyOwned>
        <classPercent>0.1%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>1,290,000</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>1,290,000</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
        <classOwnership5PercentOrLess>N</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>N</notApplicableFlag>
        <subsidiaryIdentificationAndClassification>The 1,290,000 shares referenced in this Schedule 13G are issued into the name of Uptown Capital, LLC, a Utah limited liability company. Uptown Capital, LLC is wholly-owned by Andersonville Capital, LLC, a Delaware limited liability company. Andersonville Capital, LLC is 99 percent beneficially owned by the Van Sicklen Road Trust and 1 percent beneficially owned by John M. Fife. The Van Sicklen Trust is managed by Fredrick Waid, who serves as its trustee. John M. Fife has sole voting power of Andersonville Capital, LLC.
</subsidiaryIdentificationAndClassification>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under &amp;#167; 240.14a-11.

</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>John Fife and Fredrick Waid</reportingPersonName>
      <signatureDetails>
        <signature>John Fife</signature>
        <title>John Fife</title>
        <date>01/29/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
